CA2162997A1 - Complexe fibrinogene topique - Google Patents

Complexe fibrinogene topique

Info

Publication number
CA2162997A1
CA2162997A1 CA002162997A CA2162997A CA2162997A1 CA 2162997 A1 CA2162997 A1 CA 2162997A1 CA 002162997 A CA002162997 A CA 002162997A CA 2162997 A CA2162997 A CA 2162997A CA 2162997 A1 CA2162997 A1 CA 2162997A1
Authority
CA
Canada
Prior art keywords
composition
fibrinogen
plasma
thrombin
plasminogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002162997A
Other languages
English (en)
Inventor
Daphne C. Tse
Samia S. Mankarious
Shu-Len Liu
William R. Thomas
Melaine Alpern
Stanley T. Enomoto
Cataline M. Garanchon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22860054&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2162997(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2162997A1 publication Critical patent/CA2162997A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition qui, lorsqu'elle réagit avec la thrombine, agit comme un agent de scellement à la fibrine et se caractérise en ce qu'elle est dénuée de niveaux détectables d'activité de virus enveloppé de lipide, de complexe prothrombique et de thrombine active, et ne contient ni inhibiteurs de protéase ni autres protéines non humaines. L'invention concerne également un procédé de production de ladite composition.
CA002162997A 1994-03-18 1995-03-17 Complexe fibrinogene topique Abandoned CA2162997A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22915894A 1994-03-18 1994-03-18
US08/229,158 1994-03-18

Publications (1)

Publication Number Publication Date
CA2162997A1 true CA2162997A1 (fr) 1995-09-28

Family

ID=22860054

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002162997A Abandoned CA2162997A1 (fr) 1994-03-18 1995-03-17 Complexe fibrinogene topique

Country Status (5)

Country Link
EP (1) EP0699210A1 (fr)
JP (1) JP2896235B2 (fr)
AU (1) AU695266B2 (fr)
CA (1) CA2162997A1 (fr)
WO (1) WO1995025748A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ518692A (en) * 1999-12-23 2004-08-27 Csl Ltd Purified fibrinogen free of destabilising levels of plasminogen and other proteases obtained from a Fraction I paste
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
WO2004067704A2 (fr) 2003-01-30 2004-08-12 Prochon Biotech Ltd. Matrices de fibrine lyophilisees et leurs procedes de preparation
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
WO2009111069A1 (fr) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Produits de recombinaison spongieux, particules de cartilage et associations de produits de recombinaison spongieux et de particules de cartilage
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
CN104349797B (zh) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 干止血组合物
CA2912357C (fr) 2013-06-21 2019-12-31 Ferrosan Medical Devices A/S Composition seche dilatee sous vide, et seringue pour la retenir
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
JP7395113B2 (ja) 2018-05-09 2023-12-11 フェロサン メディカル デバイシーズ エイ／エス 止血組成物を調製する方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675051B2 (en) * 1991-09-05 1997-01-23 Baxter International Inc. Topical fibrinogen complex

Also Published As

Publication number Publication date
AU1993795A (en) 1995-10-09
JP2896235B2 (ja) 1999-05-31
AU695266B2 (en) 1998-08-13
JPH08512058A (ja) 1996-12-17
WO1995025748A1 (fr) 1995-09-28
EP0699210A1 (fr) 1996-03-06

Similar Documents

Publication Publication Date Title
US5716645A (en) Topical fibrinogen complex
EP0602173B1 (fr) Composition a base de fibrinogene pour application topique
CA2162997A1 (fr) Complexe fibrinogene topique
US5330974A (en) Therapeutic fibrinogen compositions
CA2131316C (fr) Fraction thrombine du sang pour utilisation dans une procedure medicale
KR100197930B1 (ko) 피브린 실란트 딜리버리 방법
CN101214391B (zh) 一种高效生物胶封闭剂及其应用
JP3701028B2 (ja) 高純度フォンビルブラント因子の入手方法
EP0082182B1 (fr) COMPOSITION A BASE DU FACTEUR HEMOSTATIQUE VIIa ET SON PROCEDE DE PREPARATION
US20070219352A1 (en) Fibrinogen from transgenic animals
WO1992013495A1 (fr) Adhesif a base de fibrinogene
US8124075B2 (en) Enhanced biological autologous tissue adhesive composition and methods of preparation and use
CA2206670C (fr) Proteines du plasma sanguin traitees thermiquement
KR20040058194A (ko) 보관이 안정한 피브리노겐 용액
Wang et al. Preparation of fibrin glue: the effects of calcium chloride and sodium chloride
CN111569143B (zh) 一种蛇毒凝血酶原激活物及基于蛇毒凝血酶原激活物的快速止血材料
CA2367124C (fr) Fraction thrombine du sang pour utilisation dans une procedure medicale
MXPA00004085A (en) Use of tranexamic acid for the preparation of a human fibrinogen composition
CN1073605A (zh) 通过采用低温沉淀物制备的改善的生物胶

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead